IS8 Stock Overview
ifa systems AG develops and sells software products for ophthalmology worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
ifa systems AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €2.50 |
| 52 Week High | €3.40 |
| 52 Week Low | €2.00 |
| Beta | 0.78 |
| 1 Month Change | -11.35% |
| 3 Month Change | -2.34% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 4.17% |
Recent News & Updates
Recent updates
Shareholder Returns
| IS8 | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | -7.4% | -2.5% | 0.5% |
| 1Y | n/a | -25.2% | 1.3% |
Return vs Industry: Insufficient data to determine how IS8 performed against the German Healthcare Services industry.
Return vs Market: Insufficient data to determine how IS8 performed against the German Market.
Price Volatility
| IS8 volatility | |
|---|---|
| IS8 Average Weekly Movement | 16.6% |
| Healthcare Services Industry Average Movement | 3.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: IS8's share price has been volatile over the past 3 months.
Volatility Over Time: IS8's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 73 | n/a | www.ifasystems.de |
ifa systems AG develops and sells software products for ophthalmology worldwide. It offers an electronic patient file that allows data documentation from the examinations and treatments. The company’s products include ifa Lion for patient documentation and administration work; and ifa Managed Security that provides IT security solutions, such as firewall, backup, and endpoint solutions.
ifa systems AG Fundamentals Summary
| IS8 fundamental statistics | |
|---|---|
| Market cap | €6.88m |
| Earnings (TTM) | €448.00k |
| Revenue (TTM) | €8.67m |
15.3x
P/E Ratio0.8x
P/S RatioIs IS8 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IS8 income statement (TTM) | |
|---|---|
| Revenue | €8.67m |
| Cost of Revenue | €6.06m |
| Gross Profit | €2.61m |
| Other Expenses | €2.16m |
| Earnings | €448.00k |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.16 |
| Gross Margin | 30.08% |
| Net Profit Margin | 5.17% |
| Debt/Equity Ratio | 0% |
How did IS8 perform over the long term?
See historical performance and comparison